Walgreens Boots Alliance Inc (NASDAQ:WBA) Shares Bought by Burney Co.

Burney Co. raised its stake in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 179.5% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 34,324 shares of the pharmacy operator’s stock after purchasing an additional 22,045 shares during the period. Burney Co.’s holdings in Walgreens Boots Alliance were worth $2,172,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Trexquant Investment LP bought a new position in Walgreens Boots Alliance in the 1st quarter worth about $3,834,000. Wealthcare Advisory Partners LLC grew its position in Walgreens Boots Alliance by 1,730.2% in the 1st quarter. Wealthcare Advisory Partners LLC now owns 6,241 shares of the pharmacy operator’s stock worth $395,000 after purchasing an additional 5,900 shares during the last quarter. The Manufacturers Life Insurance Company grew its position in Walgreens Boots Alliance by 263.4% in the 1st quarter. The Manufacturers Life Insurance Company now owns 3,306,439 shares of the pharmacy operator’s stock worth $209,198,000 after purchasing an additional 2,396,640 shares during the last quarter. Duality Advisers LP grew its position in Walgreens Boots Alliance by 8.2% in the 1st quarter. Duality Advisers LP now owns 358,770 shares of the pharmacy operator’s stock worth $22,699,000 after purchasing an additional 27,290 shares during the last quarter. Finally, Commonwealth Equity Services LLC lifted its stake in shares of Walgreens Boots Alliance by 3.5% in the 1st quarter. Commonwealth Equity Services LLC now owns 334,023 shares of the pharmacy operator’s stock worth $21,133,000 after acquiring an additional 11,191 shares during the period. 61.60% of the stock is owned by institutional investors.

Shares of Walgreens Boots Alliance stock opened at $52.88 on Wednesday. The stock has a market cap of $47.52 billion, a P/E ratio of 8.78, a PEG ratio of 1.06 and a beta of 0.77. The company has a quick ratio of 0.38, a current ratio of 0.78 and a debt-to-equity ratio of 0.50. Walgreens Boots Alliance Inc has a 12-month low of $49.31 and a 12-month high of $86.31.



Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Tuesday, April 2nd. The pharmacy operator reported $1.64 earnings per share for the quarter, missing the consensus estimate of $1.70 by ($0.06). The company had revenue of $34.53 billion during the quarter, compared to analyst estimates of $34.57 billion. Walgreens Boots Alliance had a net margin of 3.77% and a return on equity of 22.00%. The company’s revenue was up 4.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.73 EPS. As a group, equities research analysts forecast that Walgreens Boots Alliance Inc will post 5.99 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 12th. Shareholders of record on Monday, May 20th will be given a $0.44 dividend. This represents a $1.76 annualized dividend and a yield of 3.33%. The ex-dividend date is Friday, May 17th. Walgreens Boots Alliance’s payout ratio is presently 29.24%.

A number of brokerages have recently weighed in on WBA. Pivotal Research reduced their price target on shares of Walgreens Boots Alliance from $70.00 to $60.00 and set a “hold” rating for the company in a research note on Wednesday, April 3rd. UBS Group reduced their price target on shares of Walgreens Boots Alliance from $60.00 to $49.00 and set a “sell” rating for the company in a research report on Wednesday, April 3rd. BidaskClub upgraded shares of Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research report on Thursday, May 30th. Bank of America dropped their price objective on shares of Walgreens Boots Alliance from $53.00 to $51.00 and set an “underperform” rating on the stock in a research note on Monday, June 3rd. Finally, Cowen reiterated a “hold” rating and issued a $66.00 price objective on shares of Walgreens Boots Alliance in a research note on Sunday, March 31st. Six equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and four have issued a buy rating to the company’s stock. Walgreens Boots Alliance currently has a consensus rating of “Hold” and a consensus price target of $64.89.

In other Walgreens Boots Alliance news, CAO Marco Patrick Anthony Pagni sold 20,000 shares of the firm’s stock in a transaction dated Thursday, May 9th. The shares were sold at an average price of $53.05, for a total value of $1,061,000.00. Following the completion of the sale, the chief accounting officer now owns 435,811 shares in the company, valued at approximately $23,119,773.55. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, COO Ornella Barra acquired 18,000 shares of the stock in a transaction on Wednesday, April 3rd. The stock was bought at an average price of $54.56 per share, with a total value of $982,080.00. Following the transaction, the chief operating officer now directly owns 26,425 shares in the company, valued at approximately $1,441,748. The disclosure for this purchase can be found here. Company insiders own 15.73% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This report was published by Dakota Financial News and is the property of of Dakota Financial News. If you are accessing this report on another domain, it was stolen and republished in violation of U.S. & international trademark and copyright laws. The original version of this report can be read at https://dakotafinancialnews.com/2019/06/12/walgreens-boots-alliance-inc-nasdaqwba-shares-bought-by-burney-co.html.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Recommended Story: Trading Strategy Methods for Individual Investors

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.